Your browser doesn't support javascript.
Travel vaccines throughout history.
Pavli, Androula; Maltezou, Helena C.
  • Pavli A; Department of Travel Medicine, National Public Health Organization, Athens, Greece.
  • Maltezou HC; Directorate of Research, Studies, and Documentation, National Public Health Organization, Athens, Greece. Electronic address: maltezou.helena@gmail.com.
Travel Med Infect Dis ; 46: 102278, 2022.
Article in English | MEDLINE | ID: covidwho-1677191
ABSTRACT
Vaccinations are an important component of travel medicine. Beyond protection of travelers, vaccines are administered to prevent the importation of vaccine-preventable diseases at home and at destination. Proof of immunization to travel dates back to the first smallpox vaccine, developed by Edward Jenner in 1796. However, it took one century to generate the next vaccines against cholera, rabies, and typhoid fever. During the 20th century the armamentarium of vaccines used in travelers largely expanded with yellow fever, poliomyelitis, tetravalent meningococcal, and hepatitis A vaccines. The International Certificate of Inoculation and Vaccination was implemented in 1933. Currently there are vaccines administered to travelers following risk assessment, but also vaccines required according to the 2005 International Health Regulations and vaccines required at certain countries. Finally, within less than one year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic, the first COVID-19 vaccines were launched and approved for emergency use to control the pandemic. Despite practical and ethical challenges, COVID-19 vaccine verifications have been widely used since spring 2021 in many activities, including international travel. In this article, we review the course of development of travel vaccines focusing on those for which a proof of vaccination has been or is required.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Yellow Fever / Vaccines / Meningococcal Vaccines / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Travel Med Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: J.tmaid.2022.102278

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Yellow Fever / Vaccines / Meningococcal Vaccines / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Travel Med Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: J.tmaid.2022.102278